Ubiquitin ligases as therapeutic targets in HIV-1 infection

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.2, 2008-02, pp. : 131-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SCF E3 Ubiquitin Ligases as Anticancer Targets

Current Cancer Drug Targets, Vol. 11, Iss. 3, 2011-03 ,pp. : 347-356

Bentham Science Publishers

Access to resources Recommend Favorite

The SCF-type E3 Ubiquitin Ligases as Cancer Targets

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 119-129

Bentham Science Publishers

Access to resources Recommend Favorite

E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 130-135

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 integrase and RNase H activities as therapeutic targets

By Andréola ML De Soultrait V Richard Fournier M Parissi V Desjobert C Litvak S

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 4, 2002-08 ,pp. : 433-446

Informa Healthcare

Access to resources Recommend Favorite

Proteolytic Events of HIV-1 Replication as Targets for Therapeutic Intervention

Current Pharmaceutical Design, Vol. 9, Iss. 22, 2003-08 ,pp. : 1803-1815

Bentham Science Publishers

Access to resources Recommend Favorite